Ibd

© GettyImages/AmyKerk

Pfizer backing biotechnology innovation with $120m capital outlay

By Jane Byrne

Pfizer is investing US$25m in a US developer of live biotherapeutics, Vedanta Biosciences; that project is one of four investments, totaling US$120m, made by Pfizer in the second half of 2020 under its breakthrough growth program focused on clinical stage...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers